|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-8-18
|
|
pubmed:abstractText |
Surveillance of urothelial carcinoma of the urinary bladder (UBC) patients with respect to tumour recurrence and invasiveness is crucial for therapy and prognosis. Therefore, evaluation of non-invasive methods to monitor tumour progression is of high clinical interest. The study was aimed at investigating urinary concentrations of tenascin-C splicing domains for their value as tumour surveillance markers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1432-1335
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
135
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1351-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19326143-Blotting, Western,
pubmed-meshheading:19326143-Carcinoma, Transitional Cell,
pubmed-meshheading:19326143-Case-Control Studies,
pubmed-meshheading:19326143-Cystitis,
pubmed-meshheading:19326143-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19326143-Humans,
pubmed-meshheading:19326143-Immunoenzyme Techniques,
pubmed-meshheading:19326143-Neoplasm Invasiveness,
pubmed-meshheading:19326143-Neoplasm Recurrence, Local,
pubmed-meshheading:19326143-Neoplasm Staging,
pubmed-meshheading:19326143-Prognosis,
pubmed-meshheading:19326143-Protein Structure, Tertiary,
pubmed-meshheading:19326143-Tenascin,
pubmed-meshheading:19326143-Tumor Markers, Biological,
pubmed-meshheading:19326143-Urinary Bladder,
pubmed-meshheading:19326143-Urinary Bladder Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?
|
|
pubmed:affiliation |
Institute of Pathology, University Hospital Jena, Ziegelmühlenweg 1, 07743 Jena, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
